I think DW would prefer to enter into a collaboration that would generate multi-year royalites to PNV for cell delivery rather than a sale. That makes more sense if this truly is a platform to treat various diseases as he described. There are major well-funded players in the cell delivery space, such as Novo Dordisk. DW mentioned that an article is coming out in the next couple of weeks that will list some of the potential suitors.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.22 |
Change
0.035(2.97%) |
Mkt cap ! $839.3M | |||
| Open | High | Low | Value | Volume |
| $1.16 | $1.23 | $1.15 | $2.442M | 2.051M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 13146 | $1.22 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.22 | 74026 | 13 |
View Market Depth
| Last trade - 16.10pm 16/06/2025 (20 minute delay) ? |
| PNV (ASX) Chart |